Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
End-Of-Life Care for Patients With End-Stage Heart Failure, Comparisons of International Guidelines.
Rivera FB, Choi S, Carado GP, Adizas AV, Bantayan NRB, Loyola GJP, Cha SW, Aparece JP, Rocha AJB, Placino S, Ansay MFM, Mangubat GFE, Mahilum MLP, Al-Abcha A, Suleman N, Shah N, Suboc TMB, Volgman AS. Rivera FB, et al. Am J Hosp Palliat Care. 2024 Jan;41(1):87-98. doi: 10.1177/10499091231154575. Epub 2023 Jan 27. Am J Hosp Palliat Care. 2024. PMID: 36705612 Review.
Transcatheter Aortic Valve Replacement-Associated Acute Kidney Injury: An Update.
Rivera FB, Al-Abcha A, Ansay MFM, Magalong JVU, Tang VAS, Ona HM, Miralles KA, Sausa R, Uy RAF, Lerma EV, Collado FMS, McCullough PA, Volgman AS. Rivera FB, et al. Cardiorenal Med. 2023;13(1):143-157. doi: 10.1159/000529729. Epub 2023 Feb 17. Cardiorenal Med. 2023. PMID: 36801854 Free article. Review.
Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes mellitus: A meta-analysis of placebo-controlled randomized controlled trials.
Rivera FB, Bantayan NRB, Aparece JP, Cruz LLA, Magallong JV, Pine PL, Idian-Javier AMN, Lumbang GNO, Lerma EV, Lara-Breitinger KM, Gulati M, Vijayaraghavan K. Rivera FB, et al. J Clin Lipidol. 2024 Jul-Aug;18(4):e588-e601. doi: 10.1016/j.jacl.2024.03.011. Epub 2024 Apr 4. J Clin Lipidol. 2024. PMID: 38906751
Evaluating the safety profile of semaglutide: an updated meta-analysis.
Rivera FB, Arias-Aguirre E, Aguirre Z, Ybañez MJC, Rubia JMM, Galang DJ, Lumbang GN, Ruyeras JMMJ, Magalong JV, Pine PL, Amigo JAC, Ansay MFM, Zelenkov N, Thomas SS, Vijayaraghavan K. Rivera FB, et al. Curr Med Res Opin. 2024 Sep;40(9):1495-1514. doi: 10.1080/03007995.2024.2383731. Epub 2024 Jul 27. Curr Med Res Opin. 2024. PMID: 39046272
Cardiovascular Effects of Excess Growth Hormone: How Real is the Threat?
Rivera FB, Taliño MK, Ansay MF, Mangubat GF, Mahilum ML, Menghrajani RH, Placino S, Cha SW, Aparece JP, Yu MG, Co ML, Lerma E, Vijayaraghavan K, McCullough PA. Rivera FB, et al. Rev Cardiovasc Med. 2023 Mar 23;24(4):95. doi: 10.31083/j.rcm2404095. eCollection 2023 Apr. Rev Cardiovasc Med. 2023. PMID: 39076279 Free PMC article. Review.
32 results